Scipio News

5
February
2021

The Benchtop Single-Cell Letter has launched!

The first issue of the Benchtop Single-Cell Letter is out! Each issue will focus on a theme around single-cell sciences, and you can receive the bimonthly publication simply by signing up on our website!
28
January
2021

Welcome to our two new directors!

Scipio continues its expansion in 2021 with the hiring of a VP Chief Manufacturing Officer and a Director of Bioinformatics! Pierre Chaumat and Barbara André have joined the team this January to take part in the development of the Scipio kit.
3
November
2020

The new Scipio website is here!

Scipio has been riding its initial success and significantly expanded since its inception, and a new website was required to reflect such progress! You can now find more details about the Scipio technology and the team members, but its most important feature is the launch of the new Benchtop Single-Cell blog which will focus on, well, single-cell science.
25
February
2020

Scipio bioscience announces its Series A fund raising

A total of €6.0m has been obtained from an international syndicate led by M Ventures (Amsterdam, The Netherlands), the corporate venture capital arm of Merck. The initial shareholders Seventure Partners' Quadrivum I (Paris, France) and High-Tech Gründerfonds (Bonn, Germany) participated in the capital increase, alongside additional investors Financière Arbevel (Paris, France) and Investiere Venture Capital (Zürich, Switzerland).
13
November
2017

Scipio bioscience announces its seed fund raising

A total of €1.2m has been obtained from two European seed funds: Paris, France-based Seventure Partners’ Quadrivium I seed fund and Bonn, Germany-based High-Tech Gründerfonds. These funds will fuel the reinforcement of the R&D team focused on the completion of the first prototype kit, dedicated to single-cell transcriptomic.